Evidence map›Paper›PMID 24884615›Full record

ArticleBMC genomics2014

Complete genome sequence and comparative genomic analyses of the vancomycin-producing Amycolatopsis orientalis.

Li Xu, He Huang, Wei Wei, Yi Zhong, Biao Tang, Hua Yuan, Li Zhu, Weiyi Huang, Mei Ge, Shen Yang and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Heliyon · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Applied and environmental microbiology · 2023
    Article
  11. CRISPR/Cas9-mediated genome editing in vancomycin-producing strainFrontiers in bioengineering and biotechnology · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Looking Back toAntibiotics (Basel, Switzerland) · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Li Xu
He Huang
Wei Wei
Yi Zhong
Biao Tang
Hua Yuan
Li Zhu
Weiyi Huang
Mei Ge
Shen Yang
Huajun Zheng
Weihong JiangShanghai Laiyi Center for Biopharmaceutical R&D, Shanghai 200240, China. whjiang@sibs.ac.cn.
Daijie Chen
Guo-Ping Zhao
Wei Zhao
Chinese Academy of Sciences · CNNanjing Agricultural University · CNCenter for Excellence in Molecular Plant Sciences · CNFudan University · CNChinese National Human Genome Center at Shanghai · CNShanghai Institute of Pharmaceutical Industry · CNShanghai Institutes for Biological Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmycolatopsis orientalis is the type species of the genus and its industrial strain HCCB10007, derived from ATCC 43491, has been used for large-scale production of the vital antibiotic vancomycin. However, to date, neither the complete genomic sequence of this species nor a systemic characterization of the vancomycin biosynthesis cluster (vcm) has been reported. With only the whole genome sequence of Amycolatopsis mediterranei available, additional complete genomes of other species may facilitate intra-generic comparative analysis of the genus.

resultsThe complete genome of A. orientalis HCCB10007 comprises an 8,948,591-bp circular chromosome and a 33,499-bp dissociated plasmid. In total, 8,121 protein-coding sequences were predicted, and the species-specific genomic features of A. orientalis were analyzed in comparison with that of A. mediterranei. The common characteristics of Amycolatopsis genomes were revealed via intra- and inter-generic comparative genomic analyses within the domain of actinomycetes, and led directly to the development of sequence-based Amycolatopsis molecular chemotaxonomic characteristics (MCCs). The chromosomal core/quasi-core and non-core configurations of the A. orientalis and the A. mediterranei genome were analyzed reciprocally, with respect to further understanding both the discriminable criteria and the evolutionary implementation. In addition, 26 gene clusters related to secondary metabolism, including the 64-kb vcm cluster, were identified in the genome. Employing a customized PCR-targeting-based mutagenesis system along with the biochemical identification of vancomycin variants produced by the mutants, we were able to experimentally characterize a halogenase, a methyltransferase and two glycosyltransferases encoded in the vcm cluster. The broad substrate spectra characteristics of these modification enzymes were inferred.

conclusionsThis study not only extended the genetic knowledge of the genus Amycolatopsis and the biochemical knowledge of vcm-related post-assembly tailoring enzymes, but also developed methodology useful for in vivo studies in A. orientalis, which has been widely considered as a barrier in this field.

Indexed as

Genome, BacterialActinomycetalesAmino Acid SequenceAnti-Bacterial AgentsComparative Genomic HybridizationHigh-Throughput Nucleotide SequencingMetabolic Networks and PathwaysMolecular Sequence DataMultigene FamilyPhospholipidsSequence AlignmentSequence Analysis, DNAStaphylococcus aureusVancomycinAnti-Bacterial AgentsPhospholipidsVancomycin

Identifiers

PMID24884615
PMCPMC4048454
OpenAlexW2045845680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.